drugset / Trial / NCT03668600
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
NaSingle-groupOpen-labelTreatment
Summary
Multicenter, open-label, long-term extended access treatment protocol in adult patients with a primary diagnosis of MDD.
Timeline
- Start
- 2018-08-23
- Primary completion
- 2019-07-03
- Completion
- 2019-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rapastinel | Other / unclassified | 450 mg | Intravenous |